Indeed, dietary supplement of NAD precursor nicotinamide (a form of vitamin B3) or overexpression of nicotinamide nucleotide adenylyltransferase 1 (NMNAT1) that is a key NAD-producing enzyme, prevented metabolic breakdown and rescued RGCs in mouse glaucoma [79,99]. This evidence concerns the gene NMNAT1 and glaucoma.